Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study

doi:10.3748/wjg.v18.i40.5753

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3284)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

330

HTML

2737

Figures (1-3)

217

Sum=3284

Oct 28, 2012 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 28, 2012; 18(40): 5753-5758
Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5753

Full Size Figure Download Figure

Figure 1 Delays in the arrival of the contrast agent at the target site compared with that at the reference point (0 s) are represented by red, orange, yellow, green, light blue, blue and dark blue at 0. 5 s intervals.

Citation: Shiozawa K, Watanabe M, Kikuchi Y, Kudo T, Maruyama K, Sumino Y. Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study. World J Gastroenterol 2012; 18(40): 5753-5758
URL: https://www.wjgnet.com/1007-9327/full/v18/i40/5753.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i40.5753